Corvus Pharmaceuticals, Inc.CRVSNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, modest growth trend.
Left:
||||
Free cash flow yield
Latest
-7.79%
↑ 72% above average
Average (9y)
-27.91%
Historical baseline
Range
High:-4.50%
Low:-68.97%
CAGR
+6.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -7.79% | +72.5% |
| 2023 | -28.36% | +58.9% |
| 2022 | -68.97% | -89.5% |
| 2021 | -36.40% | -9.6% |
| 2020 | -33.21% | -42.0% |
| 2019 | -23.39% | +42.9% |
| 2018 | -40.95% | -87.0% |
| 2017 | -21.90% | -60.7% |
| 2016 | -13.63% | -203.1% |
| 2015 | -4.50% | - |